Ann Intern Med

1. 
   Correction: Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19.
   Ann Intern Med. 2024 Jun 18. doi: 10.7326/ANNALS-24-00699.
   

   >> Share

   
   

   
   Antiviral Res

2. DICKEY TH, Salinas ND, Patel P, Orr-Gonzalez S, et al
   RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination.
   Antiviral Res. 2024 Jun 18:105937. doi: 10.1016/j.antiviral.2024.105937.
   

   >> Share

   
   

   
   BMJ

3. MORGAN J
   "I wasn't alone after all"-how modelling vulnerability can support staff wellbeing.
   BMJ. 2024;385:q1313.
   

   >> Share

   
   
4. ALKHALDI M
   Call to boost the profile of the Middle East and north Africa region in global health.
   BMJ. 2024;385:q1272.
   

   >> Share

   
   
5. LIMB M
   Election watch: How credible are the main parties' pledges on the NHS?
   BMJ. 2024;385:q1320.
   

   >> Share

   
   
6. OXTOBY K
   Why I . . . go adventure sailing.
   BMJ. 2024;385:q1292.
   

   >> Share

   
   
7. IRWIN EM
   Knock, knock. Who's there? It's the senior house officers trying to come back . .
   BMJ. 2024;385:q1343.
   

   >> Share

   
   
8. POLKINGHORN A
   Thank you for waiting.
   BMJ. 2024;385:q1295.
   

   >> Share

   
   
9. FEINMANN J
   Analysis reveals global post-covid surge in infectious diseases.
   BMJ. 2024;385:q1348.
   

   >> Share

   
   
10. LAUNER J
    John Launer: Faces or candlesticks? Why we need continuity in teams.
    BMJ. 2024;385:q1323.
    

    >> Share

    
    
11. O'DOWD A
    World is woefully unprepared for another pandemic, experts warn.
    BMJ. 2024;385:q1355.
    

    >> Share

    
    
12. OLIVER D
    David Oliver: Will the actions pledged in Labour's election manifesto save health and social care?
    BMJ. 2024;385:q1326.
    

    >> Share

    
    
13. BUSE K, McKee M
    UK political parties pledge to strengthen security-yet ignore health security.
    BMJ. 2024;385:q1359.
    

    >> Share

    
    
14. ENRIA L, Dwyer H, Marchant M, Beckmann N, et al
    Political dimensions of misinformation, trust, and vaccine confidence in a digital age.
    BMJ. 2024;385:e079940.
    

    >> Share

    
    
15. VISWANATH K, Lee EJ, Dryer E
    Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
    BMJ. 2024;385:e076478.
    

    >> Share

    
    
16. FEINMANN J
    GP who confronted Rishi Sunak received "hundreds" of supportive messages from doctors.
    BMJ. 2024;385:q1375.
    

    >> Share

    
    
17. LIMB M
    Avoidable mortality in England and Wales remains higher than before pandemic, data show.
    BMJ. 2024;385:q1370.
    

    >> Share

    
    
18. IACOBUCCI G
    Junior doctors offer prime minister "final chance" to avoid pre-election strike.
    BMJ. 2024;385:q1367.
    

    >> Share

    
    

    
    Int J Infect Dis

19. FARMER G, Sikdar KC, Lo T, Conly J, et al
    Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity matched retrospective cohort study of a pan-provincial program in Alberta, Canada.
    Int J Infect Dis. 2024 Jun 14:107136. doi: 10.1016/j.ijid.2024.107136.
    

    >> Share

    
    
20. HUIBERTS AJ, van den Hof S, Knol MJ
    Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022.
    Int J Infect Dis. 2024 Jun 18:107127. doi: 10.1016/j.ijid.2024.107127.
    

    >> Share

    
    

    
    J Infect

21. MIKOLAJCZYK R, Diexer S, Klee B, Pfrommer L, et al
    Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO).
    J Infect. 2024 Jun 17:106206. doi: 10.1016/j.jinf.2024.106206.
    

    >> Share

    
    
22. KAJIHARA T, Yahara K, Kamigaki T, Hirabayashi A, et al
    Effects of coronavirus disease 2019 on the spread of respiratory-transmitted human-to-human bacteria.
    J Infect. 2024 Jun 17:106201. doi: 10.1016/j.jinf.2024.106201.
    

    >> Share

    
    
23. LIU B, Xu L, Ma Y, Wang H, et al
    Evidence of immunity gap: Decline in antibodies against M. pneumoniae during the COVID-19 pandemic.
    J Infect. 2024 Jun 18:106209. doi: 10.1016/j.jinf.2024.106209.
    

    >> Share

    
    

    
    J Med Virol

24. BLANGY-LETHEULE A, Vergnaud A, Dupas T, Habert D, et al
    Value of a secretomic approach for distinguishing patients with COVID-19 viral pneumonia among patients with respiratory distress admitted to intensive care unit.
    J Med Virol. 2024;96:e29756.
    

    >> Share

    
    
25. ALMANZAR G, Koosha K, Vogt T, Stein A, et al
    Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2.
    J Med Virol. 2024;96:e29739.
    

    >> Share

    
    
26. TANG Y, Zou X, Liu P, Dai Y, et al
    Human umbilical cord-derived mesenchymal stem cell transplantation improves the long COVID.
    J Med Virol. 2024;96:e29757.
    

    >> Share

    
    
27. KARBIENER M, Kindle G, Meyts I, Seppanen MRJ, et al
    Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.
    J Med Virol. 2024;96:e29738.
    

    >> Share

    
    
28. ZHU W, Gu L
    Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023-2024 season in Beijing showing increased population susceptibility.
    J Med Virol. 2024;96:e29751.
    

    >> Share

    
    

    
    J Virol

29. CHEN Z, Cui Q, Ran Y, Achi JG, et al
    A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
    J Virol. 2024 Jun 20:e0050424. doi: 10.1128/jvi.00504.
    

    >> Share

    
    
30. STAHL-HENNIG C, Peter AS, Cordsmeier A, Stolte-Leeb N, et al
    Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model.
    J Virol. 2024 Jun 20:e0062824. doi: 10.1128/jvi.00628.
    

    >> Share

    
    
31. PAN R, Li P, Meyerholz DK, Perlman S, et al
    Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice.
    J Virol. 2024 Jun 18:e0058424. doi: 10.1128/jvi.00584.
    

    >> Share

    
    

    
    JAMA

32. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    

    >> Share

    
    
33. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    

    >> Share

    
    
34. HARRIS E
    Microneedle Vaccine Patches Generated Immune Response in Children.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
    

    >> Share

    
    

    
    Lancet

35. ZAROCOSTAS J
    Mental health in emergencies requires "a major rethink".
    Lancet. 2024;403:2582.
    

    >> Share

    
    
36. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    

    >> Share

    
    
37. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    

    >> Share

    
    
38. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    

    >> Share

    
    
39. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    

    >> Share

    
    
40. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    

    >> Share

    
    

    
    N Engl J Med

41. SAMET JH, El-Bassel N, Winhusen TJ, Jackson RD, et al
    Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
    N Engl J Med. 2024 Jun 16. doi: 10.1056/NEJMoa2401177.
    

    >> Share

    
    

    
    Nature

42. LINDEBOOM RGH, Worlock KB, Dratva LM, Yoshida M, et al
    Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.
    Nature. 2024 Jun 19. doi: 10.1038/s41586-024-07575.
    

    >> Share

    
    
43. ISRAELOW B, Iwasaki A
    First encounter with SARS-CoV-2: immune portraits of COVID susceptibility.
    Nature. 2024 Jun 19. doi: 10.1038/d41586-024-01644.
    

    >> Share

    
    
44. NURSE P
    We can make the UK a science superpower - with a radical political manifesto.
    Nature. 2024;630:532.
    

    >> Share

    
    
45. RIVA L, Yuan S, Yin X, Martin-Sancho L, et al
    Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
    Nature. 2024 Jun 18. doi: 10.1038/s41586-024-07659.
    

    >> Share

    
    
46. KULKARNI S
    AI and Euro 2024: VAR is shaking up football - and it's not going away.
    Nature. 2024;630:538-539.
    

    >> Share

    
    
47. CASTELVECCHI D
    CERN's $17-billion supercollider in question as top funder criticizes cost.
    Nature. 2024;630:539-540.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share